Cargando…
Different anti‐Műllerian hormone (AMH) levels respond to distinct ovarian stimulation methods in assisted reproductive technology (ART): Clues to better ART outcomes
PURPOSE: We asked whether the relationship between anti‐Műllerian hormone (AMH) value and the response to ovarian stimulation (OS) might be AMH value‐related and differ for each regimen, aiming at getting clues as to how to choose OS protocols according to AMH levels. We further addressed how AMH va...
Autores principales: | Ishii, Rena, Tachibana, Naoyuki, Okawa, Riho, Enomoto, Megumi, Asami, Mai, Toriumi, Rena, Hamada, Michiko, Horikawa, Michiharu, Akiba, Yoko, Taketani, Yuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613008/ https://www.ncbi.nlm.nih.gov/pubmed/31312105 http://dx.doi.org/10.1002/rmb2.12270 |
Ejemplares similares
-
A novel orally active gonadotropin‐releasing hormone antagonist, relugolix, is a potential substitute for injectable GnRH antagonists in controlled ovarian stimulation in assisted reproductive technology
por: Hamada, Michiko, et al.
Publicado: (2021) -
The addition of dydrogesterone improves the outcomes of pregnant women with low progesterone levels when receiving vaginal progesterone alone as luteal support in HRT‐FET cycles
por: Toriumi, Rena, et al.
Publicado: (2023) -
Identifying a possible factor for the increased newborn size in singleton pregnancies after assisted reproductive technology using cryopreserved embryos, in comparison with fresh embryos
por: Ishii, Rena, et al.
Publicado: (2018) -
The relationship between anti-Müllerian hormone (AMH) levels and pregnancy outcomes in patients undergoing assisted reproductive techniques (ART)
por: Umarsingh, Shalini, et al.
Publicado: (2020) -
Regulation of anti-Müllerian hormone (AMH) in males and the associations of serum AMH with the disorders of male fertility
por: Xu, Hui-Yu, et al.
Publicado: (2019)